JPH0350285A - Lipid peroxide decomposing agent composition - Google Patents
Lipid peroxide decomposing agent compositionInfo
- Publication number
- JPH0350285A JPH0350285A JP18491089A JP18491089A JPH0350285A JP H0350285 A JPH0350285 A JP H0350285A JP 18491089 A JP18491089 A JP 18491089A JP 18491089 A JP18491089 A JP 18491089A JP H0350285 A JPH0350285 A JP H0350285A
- Authority
- JP
- Japan
- Prior art keywords
- lipid peroxide
- present
- sodium
- agent composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Lipid peroxide Chemical class 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 13
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 11
- 238000000354 decomposition reaction Methods 0.000 claims description 12
- 235000006708 antioxidants Nutrition 0.000 abstract description 12
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 abstract description 11
- 235000010378 sodium ascorbate Nutrition 0.000 abstract description 11
- 229960005055 sodium ascorbate Drugs 0.000 abstract description 11
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 abstract description 11
- OGMQNMUHVLRDRT-UHFFFAOYSA-J disodium;3-[20-(carboxylatomethyl)-18-(dioxidomethylidene)-8-ethenyl-13-ethyl-3,7,12,17-tetramethyl-2,3-dihydroporphyrin-23-id-2-yl]propanoate;hydron;iron(2+) Chemical compound [H+].[Na+].[Na+].[Fe+2].C1=C([N-]2)C(CC)=C(C)C2=CC(C(=C2C)C=C)=NC2=CC(C(C2CCC([O-])=O)C)=NC2=C(CC([O-])=O)C2=NC1=C(C)C2=C([O-])[O-] OGMQNMUHVLRDRT-UHFFFAOYSA-J 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000008311 hydrophilic ointment Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000004032 porphyrins Chemical class 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 3
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 150000003681 vanadium Chemical class 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- ZLAPRWXYGQOKQC-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC ZLAPRWXYGQOKQC-UHFFFAOYSA-N 0.000 description 1
- DLNUHLNXAUGFKN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;iron Chemical compound [Fe].OCCN(CCO)CCO DLNUHLNXAUGFKN-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000004698 iron complex Chemical class 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HCIIFBHDBOCSAF-UHFFFAOYSA-N octaethylporphyrin Chemical compound N1C(C=C2C(=C(CC)C(C=C3C(=C(CC)C(=C4)N3)CC)=N2)CC)=C(CC)C(CC)=C1C=C1C(CC)=C(CC)C4=N1 HCIIFBHDBOCSAF-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 108010052815 scorpine Proteins 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、過酸化脂質分解剤組成物に関し、さらに詳し
くはポルフィリン金属錯体と抗酸化剤を有効成分とする
化粧品、医薬品、食品等に有用な過酸化脂質分解剤組成
物に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a lipid peroxide decomposition agent composition, and more specifically, it is useful for cosmetics, pharmaceuticals, foods, etc. containing a porphyrin metal complex and an antioxidant as active ingredients. The present invention relates to a lipid peroxide decomposition agent composition.
[従来の技術]
加齢に伴い、フリーラジカルの反応産物が着実に体内に
蓄積してくることは従来から知られている。これらの反
応産物は生体の生理機能の円滑な回転に支障をきたした
り、少なくとも一部の老化現象とふかく結びついている
可能性が高いと考えられてきた。[Prior Art] It has been known that free radical reaction products steadily accumulate in the body as we age. It has been thought that these reaction products interfere with the smooth functioning of the physiological functions of living organisms, and are highly likely to be closely linked to at least some aging phenomena.
また、最近生体内のフリーラジカル反応産物(ハイドロ
パーオキサイド)を直接電場する試みがなされており、
特にマウス、ウサギおよびヒトの皮膚中のハイドロパー
オキサイドの借と加齢との関係について調べると、ある
一定の年齢を越すとハイドロパーオキサイドの量が急激
に増大するという報告もなされている[例えばアール・
デイ−・リップマン、エクスベリメンタル ゼロントO
ジー、 1988年、第20巻、第1〜5頁(R,D。Recently, attempts have been made to directly apply an electric field to free radical reaction products (hydroperoxides) in living organisms.
In particular, when examining the relationship between the amount of hydroperoxide in the skin of mice, rabbits, and humans and aging, it has been reported that the amount of hydroperoxide increases rapidly after a certain age [e.g. R·
Day Lipman, Experimental Zeront O
G., 1988, Vol. 20, pp. 1-5 (R, D.
L ippman、 Experimental Ge
rontoloay vol、20 。L ippman, Experimental Ge
rontoloay vol, 20.
p1〜5.1988)参照]。p1-5.1988)].
このような皮膚の増悪因子である過酸化脂質を分解する
物質として、ビタミンB2またはビタミンB2酪酸エス
テル等が報告されている。Vitamin B2, vitamin B2 butyrate, and the like have been reported as substances that decompose lipid peroxide, which is a factor in skin aggravation.
[発明が解決しようとする問題点]
しかしながら、上記の物質は実際に皮膚に存在している
レベルの過酸化脂質に対しては、皮脂等との相溶性の問
題もあり、実際には十分な過酸化脂質分解効果が認めら
れないのが現状である。[Problems to be Solved by the Invention] However, the above-mentioned substances have problems with their compatibility with sebum, etc. against the level of lipid peroxide actually present in the skin; At present, no lipid peroxide decomposition effect has been observed.
従って、本発明の目的は十分な過酸化脂質分解効果を有
し、生体由来の過酸化脂質の蓄積を低下させ、かつそれ
自体の臭いの悪化をも防止することのできる過酸化脂質
分解剤組成物を提供することにある。Therefore, the object of the present invention is to provide a lipid peroxide decomposing agent composition that has a sufficient lipid peroxide decomposition effect, can reduce the accumulation of lipid peroxide of biological origin, and can also prevent deterioration of its own odor. It's about providing things.
[問題点を解決するための手段]
本発明者らは、上記事情に鑑み、鋭意検討した結果、ポ
ルフィリン金属錯体と抗酸化剤を有効成分とする組成物
が強い過酸化脂質分解作用を有することを見出し、本発
明を完成するに至った。[Means for Solving the Problems] In view of the above circumstances, the present inventors have made extensive studies and found that a composition containing a porphyrin metal complex and an antioxidant as active ingredients has a strong lipid peroxide decomposition effect. They discovered this and completed the present invention.
すなわち、本発明の上記目的は、少なくともポルフィリ
ン金属錯体と抗酸化剤を含有する過酸化脂質分解剤組成
物を提供することによって達成される。That is, the above object of the present invention is achieved by providing a lipid peroxide decomposer composition containing at least a porphyrin metal complex and an antioxidant.
本発明の過酸化脂質分解剤組成物は、具体的には、水も
しくはアルコール水溶液または油性物質にポルフィリン
金属錯体と抗酸化剤とを配合する(共存させる)ことに
より得られる。Specifically, the lipid peroxide decomposition agent composition of the present invention can be obtained by blending (coexisting with) a porphyrin metal complex and an antioxidant in water, an aqueous alcohol solution, or an oily substance.
上記ポルフィリン金R錯体および抗酸化剤の配合量は本
発明の過酸化脂質分解剤組成物、例えば化粧品、医薬品
、食品またはこれらの原料等に対して各々好ましくは0
.001〜5重量%、更に好ましくは0.01〜2f4
ffi%である。またポルフィリン金属錯体と抗酸化剤
の割合としては重量比で1:9〜10:1が好ましく、
更に1:5〜5:1、特に1:3〜1:1が好ましい。The amounts of the above-mentioned porphyrin gold R complex and antioxidant are preferably 0 for each of the lipid peroxide decomposer composition of the present invention, such as cosmetics, pharmaceuticals, foods, or raw materials thereof.
.. 001 to 5% by weight, more preferably 0.01 to 2f4
ffi%. In addition, the ratio of the porphyrin metal complex to the antioxidant is preferably 1:9 to 10:1 by weight,
Furthermore, the ratio is preferably 1:5 to 5:1, particularly 1:3 to 1:1.
本発明におけるポルフィリン金属錯体は、ポルフィリン
骨格の中心に金属が配位した金属錯体であって、例えば
プロトポルフィリン、ヘマトポルフィリン、スルホン化
テトラポルフィリン、クロロフィリン、フェオフォルバ
イト、ピロフェオフォルバイト、スルホン化フタロシア
ニン又はそれらのアルカリ金属塩(ナトリウム塩、カリ
ウム塩)の銅、鉄、亜鉛、コバルト、マンガン、ニッケ
ル、マグネシウム、バナジウム錯体、テトラフェニルポ
ルフィリン、オクタエチルポルフィリン、フェオフィチ
ン、メチルフェオフォルバイト、メチルピロフェオフォ
ルバイトの銅、鉄、亜鉛、コバルト、マンガン、ニッケ
ル、マグネシウム、バナジウム錯体等が好ましい。これ
らのポルフィリン金属錯体は単独あるいは2種以上組合
せて使用される。The porphyrin metal complex in the present invention is a metal complex in which a metal is coordinated to the center of a porphyrin skeleton, such as protoporphyrin, hematoporphyrin, sulfonated tetraporphyrin, chlorophyrin, pheophorbite, pyropheophorbite, sulfonated phthalocyanine. or their alkali metal salts (sodium salt, potassium salt) such as copper, iron, zinc, cobalt, manganese, nickel, magnesium, vanadium complexes, tetraphenylporphyrin, octaethylporphyrin, pheophytin, methylpheophorbite, methylpyropheophor Partite copper, iron, zinc, cobalt, manganese, nickel, magnesium, vanadium complexes, etc. are preferred. These porphyrin metal complexes may be used alone or in combination of two or more.
本発明に用いられる抗酸化剤としては、例えばアスコル
ビン酸またはそのナトリウム塩もしくはカリウム塩、ア
スコルビン酸脂肪酸エステル、エリソルビン酸またはそ
のナトリウム塩もしくはカリウム塩、BHTlBHA、
フィチン酸、トコフェロール、ハイドロキノン、タンニ
ン等が挙げられる。これ等の抗酸化剤は単独であるいは
2種以上組合せて使用される。Examples of the antioxidant used in the present invention include ascorbic acid or its sodium salt or potassium salt, ascorbic acid fatty acid ester, erythorbic acid or its sodium salt or potassium salt, BHTlBHA,
Examples include phytic acid, tocopherol, hydroquinone, and tannin. These antioxidants may be used alone or in combination of two or more.
またポルフィリン金属錯体および抗酸化剤が溶解または
分散している組成物の形態としては特に制限されずこれ
らが水系または油系を問わず配合されている各種の化粧
品、医薬品、食品等において効果を発揮する。In addition, the form of the composition in which the porphyrin metal complex and the antioxidant are dissolved or dispersed is not particularly limited, and it is effective in various cosmetics, pharmaceuticals, foods, etc. in which they are blended, regardless of whether they are water-based or oil-based. do.
本発明に係る過酸化脂質分解剤組成物には、上記の必須
構成成分の他に一般的に医薬品、医薬部外品、化粧料、
食品等に配合される成分を任意に配合することができる
。それらの成分としてはグリセリン、プロピレングリコ
ール等の多価アルコール、流動パラフィン、スクワラン
、高級脂肪酸、高級アルコール等の油分、クエン酸、乳
酸などの有機酸類、苛性ソーダ、トリエタノールアミン
等のアルカリ類、高級アルキル硫酸エステル塩、高級ア
ルキルエーテル硫酸エステル塩、高級脂肪酸アミドスル
ホン酸塩、高級アルキルスルホコハク酸塩、アルキルベ
ンゼンスルホン酸塩、アシルグルタミン酸塩、高級アル
キルリン酸塩等のアニオン性界面活性剤、高級アルキル
四級アンモニウム塩、脂肪酸アミン塩、アルキルピリジ
ニウム塩等のカチオン性界面活性剤、カルボキシベタイ
ン、スルホベタイン、イミダシリン誘導体等の両性界面
活性剤、ポリオキシエチレンアルキルエーテル、ポリオ
キシエチレン脂肪酸アミド、ソルビタン脂肪酸エステル
、脂肪酸アルカノールアミド、ポリグリセリン脂肪酸エ
ステル等の非イオン性界面活性剤、ビタミンC1ビタミ
ンE、グリチルリチン酸、サポニン、タンニン、ヒノキ
チオール、ブラセンタエキス等の各種薬剤、マルチトー
ル、コンドロイチン硫酸、ヒアルロン酸、乳酸ナトリウ
ム等の保湿剤、粉末、顔料、染料、防腐防ぽい剤、酸化
防止剤、紫外線吸収剤、キレート剤、増結剤、アルコー
ル、水、香料等が挙げられる。In addition to the above-mentioned essential components, the lipid peroxide decomposition agent composition according to the present invention generally includes pharmaceuticals, quasi-drugs, cosmetics,
Components that are mixed into foods and the like can be added arbitrarily. These components include polyhydric alcohols such as glycerin and propylene glycol, oils such as liquid paraffin, squalane, higher fatty acids and higher alcohols, organic acids such as citric acid and lactic acid, alkalis such as caustic soda and triethanolamine, and higher alkyls. Anionic surfactants such as sulfate ester salts, higher alkyl ether sulfate ester salts, higher fatty acid amide sulfonates, higher alkyl sulfosuccinates, alkylbenzene sulfonates, acyl glutamates, higher alkyl phosphates, higher alkyl quaternary Cationic surfactants such as ammonium salts, fatty acid amine salts, alkylpyridinium salts, amphoteric surfactants such as carboxybetaine, sulfobetaine, imidacillin derivatives, polyoxyethylene alkyl ethers, polyoxyethylene fatty acid amides, sorbitan fatty acid esters, fatty acids Nonionic surfactants such as alkanolamide and polyglycerin fatty acid ester, various drugs such as vitamin C1, vitamin E, glycyrrhizinic acid, saponin, tannin, hinokitiol, and brassenta extract, maltitol, chondroitin sulfate, hyaluronic acid, sodium lactate, etc. Examples include humectants, powders, pigments, dyes, preservatives, anti-oxidants, ultraviolet absorbers, chelating agents, thickeners, alcohol, water, fragrances, and the like.
[発明の効果]
本発明の過酸化脂質分解剤組成物は、以下のような効果
を与える。[Effects of the Invention] The lipid peroxide decomposition agent composition of the present invention provides the following effects.
(1)製品のにおい悪化を抑える。(1) Suppress product odor deterioration.
(2)本発明の組成物適用部位の生体由来の過酸化脂質
を低下させる。(2) Decreasing lipid peroxide of biological origin at the application site of the composition of the present invention.
[実施例]
以下に、実施例により、本発明をさらに詳細に説明する
が本発明は、これら実施例のみに限定されるものではな
い。[Examples] Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.
実施例1
トリエチレングリコール(半柱化学製)の50%水溶液
中に鉄クロロフィリンナトリウム(和光純薬工業)10
111(lおよびアスコルビン酸ナトリウム110ll
1を添加し溶解して本発明の過酸化脂質分解剤組成物(
本発明の試料1)10gを作成した。Example 1 Iron chlorophyllin sodium (Wako Pure Chemical Industries) 10% in a 50% aqueous solution of triethylene glycol (Hanbashira Kagaku)
111 (l and 110 l of sodium ascorbate
1 is added and dissolved to obtain the lipid peroxide decomposition agent composition of the present invention (
Sample 1) of the present invention (10 g) was prepared.
これを50℃恒温槽中で6日間保存後、におい判定を行
なった。After storing this in a thermostat at 50° C. for 6 days, the odor was evaluated.
比較として、上記鉄クロロフィリンナトリウム及びアス
コルごン酸ナトリウムを添加しないトリエチレングリコ
ール(比較試料1)、上記本発明のアスコルビン酸ナト
リウムと同情の7スコルビン酸のみを添加したトリエチ
レングリコール(比較試料2)、同じく本発明のアスコ
ルビン酸ナトリウムと間借のミックストコフェロールの
みを添加したトリエチレングリコール(比較試料3)を
それぞれ用いて本発明の試料1と同様のにおい判定を行
なった。For comparison, triethylene glycol without the addition of sodium iron chlorophyllin and sodium ascorbate (comparative sample 1), and triethylene glycol with only the sodium ascorbate of the present invention and the same 7-scorbic acid added (comparative sample 2). Similarly, the same odor evaluation as Sample 1 of the present invention was conducted using triethylene glycol (Comparative Sample 3) to which only sodium ascorbate of the present invention and mixed tocopherol (comparative sample 3) were added.
専門パネラ−3名による判定結果を表−1にホす。Table 1 shows the judgment results by three expert panelists.
表−1
実施例2
ニラコールHCO−60(日光ケミカル社製)0.2g
を含む50%エタノール水溶液中に銅クロロフイリンナ
トリウム10m0、アスコルビン酸ナトリウム10II
gをそれぞれ添加して溶解し、10りの過酸化脂質分解
剤組成物試料2(本発明の試料2)を作成した。また、
試料2における銅クロロフイリンナトリウムをピロフェ
オフォルバイト鉄錯体110ll1に、アスコルビン酸
ナトリウムの添加けを20mgにかえた試料3、試料2
のアスコルビン酸ナトリウムの添加量を70maにかえ
た試料4及び試料2の銅クロロフイリンナトリウムの添
加量を50111(+にかえた試料5を各々作成した。Table-1 Example 2 Niracol HCO-60 (manufactured by Nikko Chemical Co., Ltd.) 0.2 g
Copper chlorophyllin sodium 10m0, sodium ascorbate 10II in 50% ethanol aqueous solution containing
g of each were added and dissolved to prepare 10 lipid peroxide decomposition agent composition samples 2 (sample 2 of the present invention). Also,
Sample 3 and Sample 2 in which sodium copper chlorophyllin in Sample 2 was changed to 110ll1 of pyropheophorbite iron complex and the addition of sodium ascorbate was changed to 20mg.
Sample 4 was prepared by changing the amount of sodium ascorbate added to 70 ma, and Sample 5 was prepared by changing the amount of sodium copper chlorophyllin added from sample 2 to 50111 (+).
これらの試料を用いて人皮膚上での本発明の組成物の効
果を試験した。These samples were used to test the effectiveness of the composition of the invention on human skin.
比較としては上記添加物のない2%HGO−60含有5
0%エタノール水溶液のみから成る比較試料4を作成し
、同様に試験を行なった。尚、各々の組成物試料の配合
量を、表−2にまとめて示す。For comparison, 2% HGO-60 containing 5 without the above additives
Comparative sample 4 consisting of only 0% ethanol aqueous solution was prepared and tested in the same manner. The amounts of each composition sample are summarized in Table 2.
試験は3名の男性パネルの背中の一部をアルミフォイル
で覆い、太陽光(6月)のちとに30分間さらした。ア
ルミフォイルで覆った部位(ダークコントロール部)と
太陽光に照射させた部位(コントロール部)および同じ
く太陽光に照射m試料を塗布し3分後の部位(試料塗布
部)から−定量のアセトンにてそれぞれ皮脂を採取し、
それぞれのTBA値(チオバルビリール酸値)を測定し
た。(測定法は花房、第22回油化学討論会146、1
983参照)ここでTBA値は、スクワレン(SQ)(
GLCにて定量)1+11(]に対する吸光度として求
めた。In the test, parts of the backs of three male panelists were covered with aluminum foil and exposed to sunlight (in June) for 30 minutes. From the area covered with aluminum foil (dark control area), the area irradiated with sunlight (control area), and the area 3 minutes after applying the sample exposed to sunlight (sample application area) - fixed amount of acetone. Collect sebum from each
The TBA value (thiobarbylic acid value) of each was measured. (Measurement method is Hanafusa, 22nd Oil Chemistry Symposium 146, 1
983) Here, the TBA value is squalene (SQ) (
It was determined as the absorbance against 1+11 (quantified by GLC).
これらの結果を表−3に示す。These results are shown in Table 3.
以下余白
表−3より、本発明の試料2〜5の塗布部のTBA値は
コントロール部、比較試料塗布部と比べて顕著に低く、
太陽光照射により増加した皮脂中の過酸化脂質を分解す
る効果に優れていることがわかる。From Table 3 below, the TBA values of the coated areas of samples 2 to 5 of the present invention are significantly lower than those of the control area and the comparative sample coated areas.
It can be seen that it is highly effective in decomposing lipid peroxide in sebum that increases due to sunlight irradiation.
つぎに、本発明の過酸化脂質分解剤組成物を用いた化粧
料、医薬品の製剤例を示す(但し配合■はすべて重量%
で表わす)。当然のことながら、本発明は、これらに限
定されるものではない。Next, examples of formulations of cosmetics and pharmaceuticals using the lipid peroxide decomposition agent composition of the present invention are shown (however, all formulations (■) are by weight).
). Naturally, the present invention is not limited to these.
製剤例1(健康ドリンク)
果糖ぶどう糖液 119蜂蜜
0.1銅クロロフイリンナト
リウム 0.01アスコルビン酸
0.01クエン酸
0.082DL−リンゴ酸 0
.041L−アスパラギン酸 002L
−アルギニン 0.02ニコチン酸
アミド 0.01グルタミン酸すト
リウム 0.001チアミンNDS
リボフラビン
ピリドキスン塩酸塩
旧−α−トコフェロール
し−リンゴ酸ナトリウム
デカグリセリルモノオレート
精製水
香料
製剤例2(乳液)
ステアリン酸
セチルアルコール
ワセリン
流動パラフィン
ポリオキシエチレン(10モル)
モノオレイン酸エステル
ポリエチレングリコール1500
トリエタノールアミン
鉄りロリンe4ナトリウム
アスコルビン酸
クエン酸ナトリウム
1.7x10−4
2.5X 10→
X1G−4
0,05
0,05
0,1
残余
適量
2.5
1.5
5.0
10、O
2,0
3,0
1,0
5,0
5,0
1
精製水 残余香料
適蚤防腐剤
適量(製法)
精製水に、ポリエチレングリコール1500、トリエタ
ノールアミン、鉄りロリンe4ナトリウム、アスコルビ
ン酸およびクエン酸ナトリウムをそれぞれ加え加熱溶解
して70℃に保つ(水相)。次に他の残りの成分を混合
し加熱融解して70℃に保つ(油相)。水相に油相を加
え予備乳化を行ないホモミキサーで均一に乳化し、乳化
後よくかき混ぜながら30℃まで冷却する。Formulation example 1 (health drink) Fructose glucose solution 119 honey
0.1 Sodium copper chlorophyllin 0.01 Ascorbic acid
0.01 citric acid
0.082DL-malic acid 0
.. 041L-Aspartic acid 002L
- Arginine 0.02 Nicotinic acid amide 0.01 Sothorium glutamate 0.001 Thiamine NDS Riboflavin pyridoxine hydrochloride Formerly -α-tocopherol - Sodium malate Decaglyceryl monooleate Purified water Perfume formulation example 2 (emulsion) Stearic acid Cetyl alcohol Vaseline Liquid paraffin polyoxyethylene (10 moles) Monooleic acid ester polyethylene glycol 1500 Triethanolamine Iron lyroline e4 sodium Ascorbate Sodium citrate 1.7x10-4 2.5X 10→ X1G-4 0,05 0, 05 0,1 Remaining appropriate amount 2.5 1.5 5.0 10, O 2,0 3,0 1,0 5,0 5,0 1 Purified water Residual fragrance
Appropriate preservative
Appropriate amount (manufacturing method) Add polyethylene glycol 1500, triethanolamine, sodium ferroline e4, ascorbic acid, and sodium citrate to purified water, dissolve by heating, and keep at 70°C (aqueous phase). Next, the remaining ingredients are mixed, heated and melted, and kept at 70°C (oil phase). The oil phase is pre-emulsified by adding the oil phase to the water phase, and the mixture is uniformly emulsified using a homomixer. After emulsification, the mixture is cooled to 30°C while stirring well.
製剤例3(軟膏剤)
γ−オリザノール 1.0鉄ビOフエ
オフオルバイト 0.1アスコルビン酸すi・
リウム 0,1親水性軟膏
残余(製法)
γ−オ゛リザノール、鉄ピロフェオフォルバイトおよび
アスコルビン酸ナトリウムを少量の親水性軟膏と十分に
混ぜあわせた後、
を徐々に加えて全■(100%)
する。Formulation example 3 (ointment) γ-oryzanol 1.0 iron biO pheophorbite 0.1 ascorbic acid i.
Rium 0,1 hydrophilic ointment
Residue (manufacturing method) After thoroughly mixing γ-oryzanol, iron pyropheophorbite, and sodium ascorbate with a small amount of hydrophilic ointment, gradually add the following to make the mixture (100%).
ただし、 である。however, It is.
(親水性軟′fR基剤)
セタノール
ポリオキシエチレン(30モル)
セチルエーテル
グリセリルモノステアレート
(自己乳化型)
流動パラフィン
白色ワセリン
メチルパラベン
ブチルパラベン
プロピレングリコール
精製水
製剤例4(バック)
ポリビニルアルコール
カルボキシメチルセルロース
残余の親水性軟膏
とし、仝質均等に
親水性軟膏基剤の処方は次に示す通り
10、0
10、0
5、0
0、1
0、1
10、0
残余
15、0
5、0
銅クロロフイリンナトリウム 1.07スコル
ピン酸すトリウム 3,0グリセリン
5,0アルコール(エタノール)
10. 0精製水
残余香料 適m防腐
剤 適グ(製法)
防腐剤を入れた精製水にカルボキシセルロースと一部の
エタノールで膨潤したポリビニルアルコールを加え、7
0℃に加温しときどきかぎまぜながら一昼夜放置する。(Hydrophilic soft 'fR base) Cetanol polyoxyethylene (30 mol) Cetyl ether glyceryl monostearate (self-emulsifying type) Liquid paraffin white petrolatum methyl paraben butyl paraben propylene glycol Purified water formulation example 4 (back) Polyvinyl alcohol carboxymethyl cellulose residue The formulation of the hydrophilic ointment base is as follows: Sodium 1.07 Sotrium scorpine 3.0 Glycerin
5,0 alcohol (ethanol)
10. 0 purified water
Residual fragrance: Preservative: Preservative (manufacturing method) Add carboxycellulose and polyvinyl alcohol swollen with some ethanol to purified water containing preservative, and add 7
Warm to 0℃ and leave overnight, stirring occasionally.
翌日鋼クロOフィリンプトリウム、アスコルビン酸ナト
リウム、グリセリン、アルコール残部、香料を加え均一
に混合しかきまぜながら冷却する。The next day, add the steel black O filymptrium, sodium ascorbate, glycerin, the remainder of the alcohol, and fragrance, mix evenly, and cool while stirring.
Claims (1)
ることを特徴とする過酸化脂質分解剤組成物。A lipid peroxide decomposition composition comprising at least a porphyrin metal complex and an antioxidant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1184910A JP2906152B2 (en) | 1989-07-18 | 1989-07-18 | Lipid peroxide decomposer composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1184910A JP2906152B2 (en) | 1989-07-18 | 1989-07-18 | Lipid peroxide decomposer composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0350285A true JPH0350285A (en) | 1991-03-04 |
JP2906152B2 JP2906152B2 (en) | 1999-06-14 |
Family
ID=16161477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1184910A Expired - Fee Related JP2906152B2 (en) | 1989-07-18 | 1989-07-18 | Lipid peroxide decomposer composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2906152B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001501976A (en) * | 1997-08-08 | 2001-02-13 | インダストリア エ コメルシオ デ コスメティコス ナチュラ リミタダ | Method for stabilizing levogyre ascorbic acid (LAA) and stable LAA composition |
JP2006169180A (en) * | 2004-12-17 | 2006-06-29 | Taisho Pharmaceut Co Ltd | Copper-containing composition for oral administration |
JP2010270222A (en) * | 2009-05-21 | 2010-12-02 | Toyota Motor Corp | Solvent composition |
WO2012043716A1 (en) * | 2010-10-01 | 2012-04-05 | 株式会社いいもの王国 | Cosmetic composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230391809A1 (en) * | 2022-06-07 | 2023-12-07 | Biomimetix Jv, Llc | Hydrophobic compositions including a hydrophilic active ingredient and methods relating thereto |
-
1989
- 1989-07-18 JP JP1184910A patent/JP2906152B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001501976A (en) * | 1997-08-08 | 2001-02-13 | インダストリア エ コメルシオ デ コスメティコス ナチュラ リミタダ | Method for stabilizing levogyre ascorbic acid (LAA) and stable LAA composition |
JP2006169180A (en) * | 2004-12-17 | 2006-06-29 | Taisho Pharmaceut Co Ltd | Copper-containing composition for oral administration |
JP2010270222A (en) * | 2009-05-21 | 2010-12-02 | Toyota Motor Corp | Solvent composition |
US8507420B2 (en) | 2009-05-21 | 2013-08-13 | Toyota Jidosha Kabushiki Kaisha | Solvent composition |
WO2012043716A1 (en) * | 2010-10-01 | 2012-04-05 | 株式会社いいもの王国 | Cosmetic composition |
JP5718348B2 (en) * | 2010-10-01 | 2015-05-13 | 株式会社アイフォーレ | Cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
JP2906152B2 (en) | 1999-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6001341A (en) | Deodorant and/or antiperspirant cosmetic compositions | |
JPS61155302A (en) | Skin color-lightening cosmetic | |
TW200815044A (en) | External preparation for skin | |
JP2010001239A (en) | Composition for external use | |
JPH05301811A (en) | Beautifying and whitening cosmetic | |
US5849309A (en) | Skin activator with glycosaminoglycan production-accelerating effect | |
JP2005120023A (en) | Skin care preparation | |
JP5835541B2 (en) | Oil-in-water emulsion base and cosmetics | |
JPH0350285A (en) | Lipid peroxide decomposing agent composition | |
JP2011213652A (en) | Skin care preparation for external use | |
JP6837470B2 (en) | Cleaning composition | |
JP2780803B2 (en) | External preparation for skin | |
JPH05201847A (en) | Skin-beautifying cosmetic | |
JP2005132828A (en) | Composition for external application | |
JPH0196109A (en) | Skin-beautifying cosmetic | |
JPH0193520A (en) | Beautifying and whitening cosmetic | |
JPH11292752A (en) | Beautifully whitening agent and composition for external use for skin | |
JPS61227517A (en) | Skin cosmetic | |
JP2786233B2 (en) | External preparation for skin | |
JPH0672855A (en) | Suppressor of melanogenesis and skin external preparation | |
JP3170024B2 (en) | Whitening cosmetics | |
JP2753639B2 (en) | Cosmetics | |
EP0640581A1 (en) | Endermic nutrient material and cosmetic composition containing the same | |
CN105726351A (en) | Synergistic composition for reducing UV-induced lipid peroxidation, preparation and related method | |
JPH11286425A (en) | Composition for suppressing aged person smell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |